With the bioinformatic analyses and biological evidence in current study, we identified a novel germline polymorphism of RPA1 gene (rs1131636) conferring tumor progression and therapeutic resistance in NPC, which ultimately affects the survival of patients with NPC. Here, RPA1 is linked to nasopharyngeal carcinoma.